Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Century Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −8 vs. Q3 2025
- Shares held
- 25.7M
- +5.43M (+26.8%) vs. Q3 2025
- Total value
- $25.6M
- +$15.5M (+153.0%) vs. Q3 2025
- New holders
- 8
- 9 more added
- Sold out
- 16
- 14 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 69 | $0 | 0.00% | −2−2.8% | Reduced |
| Citigroup Inc | 1 | $1 | 0.00% | −2,209−100.0% | Reduced |
| Barclays PLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Smartleaf Asset Management LLC | 1 | $1 | 0.00% | +1 | New |
| Optiver Holding B.V. | 32 | $32 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40 | $40 | 0.00% | +40 | New |
| SRS Capital Advisors, Inc. | 99 | $98 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 500 | $497 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 525 | $522 | 0.00% | −73−12.2% | Reduced |
| Nisa Investment Advisors, LLC | 883 | $878 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,447 | $1.44K | 0.00% | −31−2.1% | Reduced |
| SBI Securities Co., Ltd. | 1,530 | $1.52K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,397 | $2.38K | 0.00% | +2,397 | New |
| JPMorgan Chase & Co | 3,077 | $3.06K | 0.00% | +1,484+93.2% | Added |
| Advisors Asset Management, Inc. | 8,313 | $8.27K | 0.00% | −99−1.2% | Reduced |
| Scientech Research LLC | 12,355 | $12.3K | 0.01% | +12,355 | New |
| Quadrant Private Wealth Management, LLC | 15,286 | $15.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,333 | $15.3K | 0.00% | −12,225−44.4% | Reduced |
| Parametrica Management Ltd | 27,840 | $27.7K | 0.04% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 29,018 | $28.9K | 0.02% | 00.0% | Unchanged |
| Jane Street Group, LLC | 45,194 | $45.0K | 0.00% | −13,538−23.1% | Reduced |
| Susquehanna International Group, LLP | 50,104 | $49.8K | 0.00% | −17,820−26.2% | Reduced |
| Prudential Financial Inc | 59,800 | $59.5K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 77,797 | $70.0K | 0.00% | −56−0.1% | Reduced |
| FMR LLC | 71,540 | $71.2K | 0.00% | −120,599−62.8% | Reduced |
| Algert Global LLC | 76,800 | $76.4K | 0.00% | +76,800 | New |
| Raymond James Financial Inc | 91,323 | $90.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 105,052 | $104.5K | 0.00% | +38,052+56.8% | Added |
| State Street Corp | 127,443 | $126.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 214,501 | $213.4K | 0.00% | +214,164+63,550.1% | Added |
| Citadel Advisors LLC | 319,457 | $317.8K | 0.00% | −41,368−11.5% | Reduced |
| Gsa Capital Partners LLP | 333,199 | $331.0K | 0.03% | −270,280−44.8% | Reduced |
| Geode Capital Management, LLC | 456,115 | $453.9K | 0.00% | +10,806+2.4% | Added |
| Superstring Capital Management LP | 462,963 | $460.6K | 0.25% | 00.0% | Unchanged |
| BlackRock, Inc. | 601,866 | $598.7K | 0.00% | +2,210+0.4% | Added |
| Millennium Management LLC | 610,387 | $607.2K | 0.00% | −133,394−17.9% | Reduced |
| Syncona Portfolio Ltd | 1,213,056 | $1.21M | 3.52% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,217,103 | $1.21M | 0.00% | +497,295+69.1% | Added |
| Casdin Capital, LLC | 1,228,190 | $1.22M | 0.08% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 1,267,700 | $1.26M | 0.00% | +410,100+47.8% | Added |
| Renaissance Technologies LLC | 1,349,200 | $1.34M | 0.00% | −1,237,700−47.8% | Reduced |
| Spruce Street Capital LP | 1,421,532 | $1.41M | 0.47% | +1,421,532 | New |
| Two Sigma Investments, LP | 1,495,916 | $1.49M | 0.00% | +584,470+64.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,838,700 | $1.83M | 0.00% | +1,838,700 | New |
| Vanguard Group Inc | 2,103,869 | $2.09M | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 2,793,586 | $2.78M | 0.65% | +1,089,354+63.9% | Added |
| Point72 Asset Management, L.P. | 5,961,631 | $5.93M | 0.01% | +5,961,631 | New |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −3,538,609−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −236,053−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −60,682−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −54,161−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −24,018−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,113−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,501−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,116−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −11,241−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,660−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −407−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |